Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Hormone Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000182296PMID 1490653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polycystic ovarian disease: Endocrinological parameters with specific reference to growth hormone and somatomedin-C

  2004cited by this paper
• LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome.

  1990cited by this paper
• Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.

  1990cited by this paper
• Plasma levels of insulin-like growth factor-I and its binding protein in polycystic ovary syndrome.

  1990cited by this paper
• Secretory patterns of growth hormone according to sex and age.

  1990cited by this paper
• An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome.

  1990cited by this paper
• INSULIN‐LIKE GROWTH FACTOR BINDING PROTEINS IN FOLLICULAR FLUID FROM NORMAL DOMINANT AND COHORT FOLLICLES, POLYCYSTIC AND MULTICYSTIC OVARIES

  1990cited by this paper
• EFFECTS OF LUTEINIZING HORMONE, INSULIN, INSULIN‐LIKE GROWTH FACTOR‐I AND INSULINLIKE GROWTH FACTOR SMALL BINDING PROTEIN 1 IN THE POLYCYSTIC OVARY SYNDROME

  1990cited by this paper
• Levels of the small insulin-like growth factor-binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty.

  1989cited by this paper
• The etiology of polycystic ovary syndrome (PCO).

  1989cited by this paper
• Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease.

  1989cited by this paper
• Decreased 34K insulin-like growth factor binding protein in polycystic ovarian disease.

  1989cited by this paper
• Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin.

  1989cited by this paper
• Paradoxical growth hormone response following thyroid-stimulating hormone administration in the polycystic ovary syndrome.

  1989cited by this paper
• Metabolic clearance rates of synthetic human growth hormone in lean and obese male rhesus monkeys.

  1988cited by this paper
• Somatomedin-C/insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells.

  1988cited by this paper
• Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells.

  1988cited by this paper
• Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein.

  1988cited by this paper
• Pancreatic Beta Cell Function in Polycystic Ovary Syndrome: Its Relationship to Body Weight, Serum Testosterone and Serum Prolactin Levels

  1987cited by this paper
• Modulation of immunoreactive somatomedin-C levels by sex steroids.

  1986cited by this paper
• Effects of Insulin on Rat Anterior Pituitary Cells: Inhibition of Growth Hormone Secretion and mRNA Levels

  1986cited by this paper
• The Measurement of Insulin-Like Growth Factor I: Clinical Applications and Significance

  1986cited by this paper
• Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.

  1986cited by this paper
• Sexual dimorphism in the control of growth hormone secretion.

  1985cited by this paper
• Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy.

  1985cited by this paper
• Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function.

  1985cited by this paper
• Insulin resistance in polycystic ovary syndrome.

  1983cited by this paper
• Insulin and C-Peptide Levels in Obese Patients with Polycystic Ovaries

  1982cited by this paper
• Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin.

  1981cited by this paper
• The polycystic ovary syndrome.

  1980cited by this paper
• Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.

  1980cited by this paper
• The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver.

  1976cited by this paper

• Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights

  2021cites this paper
• Ascorbic Acid and Alpha-Tocopherol Contribute to the Therapy of Polycystic Ovarian Syndrome in Mouse Models

  2020cites this paper
• Current aspects of polycystic ovary syndrome I: definition, pathophysiology, clinical manifestations, diagnosis and complications

  2018cites this paper
• Hyperandrogenism in adolescent girls: relationship with the somatotrophic axis

  2017cites this paper
• Anaerobic fungi (phylum Neocallimastigomycota): advances in understanding their taxonomy, life cycle, ecology, role and biotechnological potential.

  2014cites this paper
• In polycystic ovary syndrome, adrenal steroids are regulated differently in the morning versus in response to nutrient intake.

  2010cites this paper
• Role of opioid antagonists in the treatment of women with glucoregulation abnormalities.

  2006cites this paper
• Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome

  2004cites this paper
• Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome.

  2004cites this paper
• Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome.

  2004cites this paper
• GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome

  2003cites this paper
• Serum levels of insulin-like growth factor I and its binding proteins in health and disease.

  2003cites this paper
• revisão Aspectos Neuroendócrinos na Síndrome dos Ovários Policísticos

  2003cites this paper
• Aspectos neuroendócrinos na síndrome dos ovários policísticos

  2003cites this paper
• Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting

  2003cites this paper
• Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome.

  2002cites this paper
• Microbial Cellulose Utilization: Fundamentals and Biotechnology

  2002cites this paper
• Low amplitude and disorderly spontaneous growth hormone release in obese women with or without polycystic ovary syndrome.

  2002cites this paper
• IGF-1 in gynaecology and obstetrics: update 2002.

  2002cites this paper
• Noncatalytic Docking Domains of Cellulosomes of Anaerobic Fungi

  2001cites this paper
• Endocrine and metabolic changes in women with polycystic ovaries and polycystic ovary syndrome

  2001cites this paper
• Energy balance and cancer: the role of insulin and insulin-like growth factor-I

  2001cites this paper
• Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.

  2000cites this paper
• Clinical implications of insulin-like growth factors and their binding proteins in reproduction.

  2000cites this paper
• Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.

  2000cites this paper
• after ultrasound-guided transvaginal

  1999cites this paper
• Caloric Restriction for 24 Hours Increases Mean Night Growth Hormone

  1999cites this paper
• Growth hormone kinetics in polycystic ovary syndrome.

  1999cites this paper
• Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome.

  1998cites this paper
• Abnormalities in the serum insulin-like growth factor-1 axis in women with hyperandrogenism.

  1998cites this paper
• Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease.

  1998cites this paper
• Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome.

  1998cites this paper
• Polycystic ovary syndrome and insulin resistance: Thrifty genes struggling with over-feeding and sedentary life style?

  1998cites this paper
• Involvement of growth factors in the pathophysiology of polycystic ovary syndrome.

  1998cites this paper
• The counterregulatory response to hypoglycaemia in women with the polycystic ovary syndrome

  1997cites this paper
• Leptin: a hormone of reproduction.

  1997cites this paper
• Role of Growth Hormone in Polycystic Ovarian Syndrome

  1997cites this paper
• Insulin resistance in polycystic ovary syndrome

  1997cites this paper
• Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.

  1997cites this paper
• Normal serum uric acid concentrations in women with polycystic ovary syndrome.

  1996cites this paper
• Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy.

  1996cites this paper
• Growth hormone response to GHRH, GHRP‐6 and GHRH+GHRP‐6 in patients with polycystic ovary syndrome

  1996cites this paper
• Nutrition, hormones, and breast cancer: Is insulin the missing link?

  1996cites this paper
• Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome.

  1996cites this paper
• Growth Factors and Polycystic Ovarian Syndrome

  1996cites this paper
• Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.

  1996cites this paper
• Growth hormone and fertility--clinical studies.

  1996cites this paper
• Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.

  1995cites this paper
• Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.

  1995cites this paper
• Clinical applications of growth hormone for ovarian stimulation.

  1995cites this paper
• Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.

  1995cites this paper
• Growth hormone, insulin-like growth factor-I axis, and insulin secretion in hyperandrogenic adolescents.

  1995cites this paper
• The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relationship with obesity and hyperinsulinaemia.

  1995cites this paper
• Cellulases and hemicellulases of the anaerobic fungus Piromyces constitute a multiprotein cellulose-binding complex and are encoded by multigene families.

  1995cites this paper
• Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women.

  1994cites this paper
• The biological degradation of cellulose.

  1994cites this paper
• Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.

  1994cites this paper
• Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.

  1994cites this paper
• The response of the growth hormone and insulin-like growth factor I axis to medical castration in women with polycystic ovarian syndrome.

  1994cites this paper
• Molecular genetics of obligate anaerobes from the rumen.

  1994cites this paper
• 24-hour serum cortisol profiles in women with polycystic ovary syndrome.

  1993cites this paper
• Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease.

  1993cites this paper